Nuveen LLC Buys Shares of 370,626 Teradyne, Inc. $TER

Key Points

• Nuveen LLC acquired 370,626 shares of Teradyne, Inc. for approximately $30.6 million, increasing its stake to about 0.23% of the company.
• Several institutional investors have recently made significant changes to their holdings in Teradyne, with notable acquisitions including Marshall Wace LLP increasing its stake by 557.5% in the last quarter.
• Teradyne's analyst ratings vary widely, with an average rating of "Moderate Buy" and a target price around $114.44, reflecting a mix of buy, hold, and sell recommendations.

Nuveen LLC bought a new stake in shares of Teradyne, Inc. (NASDAQ:TER - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 370,626 shares of the company's stock, valued at approximately $30,614,000. Nuveen LLC owned approximately 0.23% of Teradyne at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Aigen Investment Management LP purchased a new position in Teradyne in the 1st quarter valued at $736,000. Virtu Financial LLC purchased a new position in Teradyne in the 1st quarter valued at $1,089,000. Invesco Ltd. lifted its holdings in Teradyne by 16.1% in the 1st quarter. Invesco Ltd. now owns 2,790,898 shares of the company's stock valued at $230,528,000 after purchasing an additional 387,705 shares in the last quarter. Benjamin Edwards Inc. lifted its holdings in Teradyne by 18.5% in the 1st quarter. Benjamin Edwards Inc. now owns 12,959 shares of the company's stock valued at $1,070,000 after purchasing an additional 2,026 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Teradyne by 35.8% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 50,004 shares of the company's stock valued at $4,130,000 after purchasing an additional 13,188 shares in the last quarter. Hedge funds and other institutional investors own 99.77% of the company's stock.

Analysts Set New Price Targets

TER has been the topic of a number of research reports. The Goldman Sachs Group restated a "sell" rating and issued a $85.00 price objective on shares of Teradyne in a report on Wednesday, July 30th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $102.00 target price (up from $88.00) on shares of Teradyne in a research note on Thursday, July 17th. Cowen reaffirmed a "buy" rating on shares of Teradyne in a research note on Wednesday, July 30th. Stifel Nicolaus raised their target price on Teradyne from $85.00 to $100.00 and gave the stock a "hold" rating in a research note on Thursday, July 31st. Finally, Wall Street Zen raised Teradyne from a "sell" rating to a "hold" rating in a research note on Saturday, August 16th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $114.44.

Teradyne Price Performance

Shares of NASDAQ:TER traded up $6.6710 during midday trading on Friday, reaching $115.9710. 891,134 shares of the company's stock were exchanged, compared to its average volume of 3,468,941. The firm's 50 day simple moving average is $97.04 and its two-hundred day simple moving average is $91.28. The stock has a market cap of $18.45 billion, a price-to-earnings ratio of 40.13, a P/E/G ratio of 2.30 and a beta of 1.72. Teradyne, Inc. has a fifty-two week low of $65.77 and a fifty-two week high of $144.16.

Teradyne (NASDAQ:TER - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.54 by $0.03. The firm had revenue of $651.80 million during the quarter, compared to the consensus estimate of $649.02 million. Teradyne had a return on equity of 18.16% and a net margin of 16.59%.The company's quarterly revenue was down 10.7% on a year-over-year basis. During the same period last year, the company earned $0.86 EPS. Teradyne has set its Q3 2025 guidance at 0.690-0.870 EPS. Equities research analysts predict that Teradyne, Inc. will post 3.88 earnings per share for the current fiscal year.

Teradyne declared that its board has authorized a stock repurchase plan on Monday, April 28th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to repurchase up to 8.1% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued.

Insider Activity

In related news, CEO Gregory Stephen Smith sold 554 shares of the firm's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $106.00, for a total transaction of $58,724.00. Following the completion of the sale, the chief executive officer directly owned 96,993 shares of the company's stock, valued at approximately $10,281,258. This trade represents a 0.57% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.16% of the company's stock.

Teradyne Company Profile

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.